Abstract:Objective To evaluate the risk factors of neoatherosclerosis after coronary stent implantation through the study of optical coherence tomography (OCT) observation, and the effect of statin lipid-lowering therapy. Methods The clinical data of 40 patients with coronary heart disease (CHD) after coronary stent implantation (OCT) in Peking University First Hospital from June 2013 to June 2016 were analyzed retrospectively. The patients were divided into the target-achieved group (19 cases, LDL-C<1.8 mmol/L) and the above-target group (21 cases LDL-C ≥ 1.8 mmol/L) according to whether their low density lipoprotein (LDL) levels reached the treatment target. The medical history, biochemical parameters, medication and the qualitative and quantitative analysis of the neoatherosclerosis in the two groups were reviewed and compared. Results There were no statistical differences between the two groups in age, sex, smoking, comorbidities of hypertension, diabetes mellitus, kidney disease, history of myocardial infarction and time of stent implantation. Patients in the above-target group had higher LDL-C levels[(2.42 ± 0.79)mmol/L vs.(1.30 ± 0.35)mmol/L,P<0.001],higher cholesterol levels[(4.38 ±1.01)mmol/L vs.(3.07± 0.87)mmol/L,P<0.001], but lower statin used dosage[(15.26 ±2.30)mg/d vs.(22.38 ± 2.10)mg/d,P=0.032]as compared to patients in the target-achieved group. There was no statistical difference between the other parameter and medication profile. Qualitative analysis showed higher rates of neoatherosclerosis in the above-target group as compared to the target-achieved group(78.9% vs.38.1%,P=0.009),plus higher rates of endothelial heterogeneity(78.9% vs.38.1%,P=0.009),lipid plaque(73.7% vs.38.1%,P=0.024) and calcified plaque(26.3% vs. 4.8%,P=0.049). The rate of neointima restenosis in the above-target group was higher than that of the target-achieved group[(25.12 ±1.10)% vs.(19.70±1.10)%, P=0.001]. Logistic analysis showed that the level of low density lipoprotein(P=0.009),dosage of statin prescribed (P=0.040), male gender (P=0.042) and serum creatinine (P=0.012) were associated with the present of neonatal arteriosclerosis .Multivariate regression analysis showed levels of lipoprotein and low presence of statin dosage were the independent wish factors. Low density lipoprotein levels were positively correlated with neoatherosclerosis formation and the dosage of statin was negatively correlated (P<0.05).Conclusions In-stent restenosis after PCI is closely related to neonatal atherosclerosis. Controlling LDL-C to target levels can significantly reduce the risk of neoatherosclerosis. Intensified statin therapy strategy can prevent neoatherosclerosis in by certain extent.

Predictive value of lectin-like ox-LDL receptor-1 level to restenosis after intracoronary stent implantation

To Explore the Relationship between Clinical Serum Markers and Intracoronary in-stent Restenosis

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.

[Value of Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) and LOX-1 Mrna in Peripheral Mononuclear Cells in Early Diagnosis of Acute Coronary Syndrome].

Relationship Between Plasma Level of IL-18,ox-LDL and the Development of Emergency Percutaneous Coronary Intervention

Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography.

Alterations in Metabolome and Lipidome in Patients with In-Stent Restenosis.

Relationships between levels of antibody against oxidized low density lipoproteins and restenosis of coronary artery: Risk factor independent from age, sex, bodymass index hypertension, hyperlipemia and smoking history

Evaluation of Preprocedural Laboratory Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total Occlusion Lesions.

[Different Effects of Inflammation and Lipid Levels on Coronary Lesions after PCI].

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study

Inhibition of aflatoxin-induced serum alpha-fetoprotein in rats fed cauliflower.

Analysis of related factors of neoatherosclerosis after coronary stent implantation by optical coherence tomography

Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up

Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting

Statin Reduces In-stent Restenosis in Patients with Coronary Heart Disease; Influencing Factors and Implications

The Correlation Between Serum Bilirubinlevels and Instent-Restenosis for Coronary Heart Disease: an Angiographic Study

Correlation between lipoprotein(a) and recurrent ischemic events post-cerebral vascular stent implantation

Influential Factors of In-Stent Restenosis in Patients with Chronic Total Occlusion after Percutaneous Coronary Intervention

Higher Serum Cystatin C and Matrix Metalloproteinase 9 Levels Effectively Predict In-Stent Restenosis after Stent Implantation for Intracranial and Extracranial Arterial Stenosis

Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis